EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting α7 Nicotinic Acetylcholine Receptors in Post-Traumatic Stress Disorder: Mechanisms and Clinical Implications

Aleksandr P. Kalinovskii, Dmitry I. Osmakov, Yulia A. Logashina, Yaroslav A. Andreev, Vladimir M. Trukhan

Pharmaceutics · 30.10.2026 · 18 (11) · 1397

DOI: 10.3390/pharmaceutics18111397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 30.10.2026. Verfasst von Aleksandr P. Kalinovskii und 4 weiteren Autor:innen. Die Arbeit nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Russian Federation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-traumatic stress disorder (PTSD) is a severe disorder that is characterized by intrusive thoughts, impaired mood and cognition, hyperarousal, and avoidance in the months and years following a traumatic event. PTSD is comorbid with depression, anxiety, substance abuse, and is challenging for the treatment with psycho- and pharmacotherapy. In light of novel neurobiological findings on the pathogenesis of the disease, innovative approaches to its treatment are investigated. Recently, targeting cholinergic signaling with an antagonist of α7 nicotinic acetylcholine receptors (nAChR), BNC-210, showed a significant promise in clinical trials. This opened up a novel therapeutic strategy that, considering its translational success, calls for a mechanistic understanding. In this review, we dissect the neurobiological role of α7 nAChR in regard of PTSD, and related depression and anxiety states. We discuss the synaptic role of the receptor in fear circuits, immune and endocrine role via the anti-inflammatory cholinergic pathway, and current evidence for the utility of pharmacological modulation of α7 nAChR.

Förderung

  • Ministry of Health of the Russian Federation

Zitieren

APA

Kalinovskii, A. P., Osmakov, D. I., Logashina, Y. A., Andreev, Y. A., & Trukhan, V. M. (2026). Targeting α7 Nicotinic Acetylcholine Receptors in Post-Traumatic Stress Disorder: Mechanisms and Clinical Implications. Pharmaceutics, 18(11), 1397. https://doi.org/10.3390/pharmaceutics18111397

Vancouver

Kalinovskii AP, Osmakov DI, Logashina YA, Andreev YA, Trukhan VM. Targeting α7 Nicotinic Acetylcholine Receptors in Post-Traumatic Stress Disorder: Mechanisms and Clinical Implications. Pharmaceutics. 2026;18(11):1397. doi:10.3390/pharmaceutics18111397

BibTeX
@article{Kalinovskii2026,
  author = {Kalinovskii, Aleksandr P. and Osmakov, Dmitry I. and Logashina, Yulia A. and Andreev, Yaroslav A. and Trukhan, Vladimir M.},
  title = {Targeting α7 Nicotinic Acetylcholine Receptors in Post-Traumatic Stress Disorder: Mechanisms and Clinical Implications},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1397},
  doi = {10.3390/pharmaceutics18111397}
}
Kostenlos starten →